Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
about
DNA Methylation as Surrogate Marker For Gastric CancerPromoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancerInfluence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosaInfluence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.Gastric cancer prevention by demethylationBiomarkers of Helicobacter pylori-associated gastric cancer.Role of DNA methylation in the development of diffuse-type gastric cancer.Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis.Morphologic characterization of residual DNA methylation in the gastric mucosa after Helicobacter pylori eradication.Genome-wide DNA methylation profiles in noncancerous gastric mucosae with regard to Helicobacter pylori infection and the presence of gastric cancer.Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer.Deep learning analyzes Helicobacter pylori infection by upper gastrointestinal endoscopy images.Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae.Effect of polymorphisms of IL-1β and TNF-α genes on CpG island hyper methylation (CIHM) in the nonneoplastic gastric mucosa.Polymorphisms of DNA repair and xenobiotic genes predispose to CpG island methylation in non-neoplastic gastric mucosa.
P2860
Q26782521-3E7F9F2D-7B8F-4671-BD67-1B4CCA3C3F81Q34047716-06233689-E170-4A81-B0F8-C4509A3A259FQ34349990-CD65C5D3-C47F-422A-B004-160CD12BEF7BQ34528757-4A1A94B9-F975-48BA-A01D-EE1BA2D43EE2Q36750927-5B242106-1B5B-46AC-AD15-CCB751706551Q37591506-A518A5BB-40AB-4247-8F08-CB83B0F2919AQ37832910-9BFB86B3-1BC4-4B48-AF4B-5D38744E3ACEQ40327215-D153F92B-6317-4779-A78D-2A1441B3E70FQ40975827-84ED7C0F-6326-42B7-AC00-592567EE149FQ44995132-A16AC82B-EBB5-48F4-BE89-1AC7CB89DE66Q46486719-E79D1173-3A75-4E31-A03F-C33A62C82AF7Q49332115-1F55E2C4-AE15-420D-9861-57D5E9CDD3DDQ51542785-707977DA-78BF-4EC2-84C3-DE09BD0CFBC1Q53289202-C0077764-B4EB-434B-B815-158A2FC168B7Q54381384-74401C2B-1BC9-4B8D-B238-C066AC591F15
P2860
Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Risk prediction of gastric can ...... neoplastic gastric epithelium.
@en
Risk prediction of gastric can ...... neoplastic gastric epithelium.
@nl
type
label
Risk prediction of gastric can ...... neoplastic gastric epithelium.
@en
Risk prediction of gastric can ...... neoplastic gastric epithelium.
@nl
prefLabel
Risk prediction of gastric can ...... neoplastic gastric epithelium.
@en
Risk prediction of gastric can ...... neoplastic gastric epithelium.
@nl
P2093
P2860
P356
P1433
P1476
Risk prediction of gastric can ...... neoplastic gastric epithelium.
@en
P2093
Fang Yu Wang
Hiroshi Fujita
Hiroshi Nakano
Ichiro Hirata
Kazuya Takahama
Makoto Watanabe
Masahiko Nakamura
Masakatsu Nakamura
Masami Iwata
Mikijyu Sakata
P2860
P356
10.1159/000101775
P577
2007-04-16T00:00:00Z